2023-08-03 07:52:43 ET
- Henry Schein ( NASDAQ: HSIC ) said it signed an agreement to acquire a majority stake in Shield Healthcare, advancing its Henry Schein Medical’s continuum-of-care delivery model.
- With this acquisition, company's homecare medical products platform will have a revenue base of more than $300 million in annualized revenue.
- The Shield Healthcare transaction enhances Henry Schein's existing medical business by delivering a wide range of products, including incontinence, urology, ostomy, enteral nutrition, advanced wound, and diabetes supplies, as well as continuous glucose monitoring devices, directly to patients in their homes.
- Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and accretive thereafter.
- Financial terms were not disclosed.
- HSIC -0.0% after hours to $79.71
- Source: Press Release
For further details see:
Henry Schein expands its continuum-of-care delivery model with new acquisition